M
Mohammad Taghi Bahreyni Toossi
Researcher at Mashhad University of Medical Sciences
Publications - 64
Citations - 606
Mohammad Taghi Bahreyni Toossi is an academic researcher from Mashhad University of Medical Sciences. The author has contributed to research in topics: Dosimetry & Brachytherapy. The author has an hindex of 11, co-authored 62 publications receiving 486 citations. Previous affiliations of Mohammad Taghi Bahreyni Toossi include Isfahan University of Medical Sciences.
Papers
More filters
Journal ArticleDOI
An effective hair removal algorithm for dermoscopy images.
Mohammad Taghi Bahreyni Toossi,Hamid Reza Pourreza,H. Zare,Mohamad Hoseyn Sigari,Pouran Layegh,Abbas Azimi +5 more
TL;DR: A new scheme that automatically detects and removes hairs from dermoscopy images is presented that will help in the precise segmentation and analysis of the skin lesions.
Journal ArticleDOI
Radiation dose to newborns in neonatal intensive care units.
TL;DR: DRLs for neonates in the authors' province were slightly higher than values reported by other studies such as European national diagnostic reference levels and the NRPB reference dose, which was related to using a high mAs and a low kVp applied in most departments and also a low focus film distance (FFD).
Journal ArticleDOI
A Monte Carlo study on tissue dose enhancement in brachytherapy: a comparison between gadolinium and gold nanoparticles.
Mohammad Taghi Bahreyni Toossi,Mahdi Ghorbani,Mohammad Mehrpouyan,Fateme Akbari,Leila Sobhkhiz Sabet,Ali S. Meigooni +5 more
TL;DR: GdNPs can be used as a high atomic number material to enhance dose in tumour volume with dose enhancements up to 106.1 % when used in brachytherapy and gold nanoparticles can have more clinical usefulness as dose enhancer material.
Journal ArticleDOI
Doses to patients in some routine diagnostic X-ray examinations in Iran: proposed the first Iranian diagnostic reference levels.
TL;DR: The proposed Iranian DRLs are compared with the international reference dose values reported by the European Commission, the International Atomic Energy Agency and the National Radiological Protection Board.
Journal ArticleDOI
Bax/Bcl-2 expression ratio in prediction of response to breast cancer radiotherapy.
TL;DR: Significant correlation between Bax/Bcl-2 ratio determined before radiation therapy and clinical response in the patients, can be used as a biomarker to identify radiosensitive individuals, however, further studies are required to validate radiation-induced apoptotic biomarkers.